Skip to main content

uniQure N.V.

QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001590560

In the last 90 days, uniQure N.V. insiders filed 0 open-market purchases and 1 sale; 257 institutions reported holding it in 13F filings for Q2 2026, worth $3.02B in total; Maverick Capital is the only superinvestor holding it.

Key figures

Market capClose on Nov 16, 2026
$1.53B
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $192.9K in total
1
13F holdersQ2 2026, +41 vs. previous quarter
257
13F valueReported value at the end of Q2 2026
$3.02B
Superinvestors holdingAt the end of Q2 2026
1

Price chart

From SEC filings, in USD.

Revenue, FY2025
$16.1M
−40.6% year over year
Net income, FY2025
-$199.0M
No comparable prior period
Free cash flow, FY2025
-$178.4M
No comparable prior period
Revenue, Q3 FY2026
$5.20M
+40.4% year over year

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
8.51M
Shares sold short
Change
−219.1K
−2.5% vs. previous
Days to cover
6.39
At average daily volume

Superinvestors holding QURE, Q2 2026

Go to the superinvestors tab

1 superinvestor reports holding uniQure N.V. on Form 13F. Percentages are the stock's share of each portfolio.

Maverick Capital

Lee Ainslie

0.4%

uniQure N.V.'s share of the portfolio

Shares
925,383
Value
$42.6M

Latest insider trades

See all insider trades

Open-market purchases and sales by uniQure N.V. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 10, 2026 (view filing)4:04 PM ETNov 64 daysMeek David D.DirectorSSale−9.08K$21.25−$192.9K−22.8%30.7K after10b5-1
Jul 7, 2026 (view filing)4:47 PM ETJul 25 daysKapusta Matthew CCEO, Managing DirectorSSale−21.1K$45.16−$952.1K−3.9%519.2K after3 lots10b5-1
Jul 2, 2026 (view filing)4:59 PM ETJun 302 daysAbi-Saab WalidChief Medical OfficerSSale−30.0K$46.42−$1.39M−16.8%148.2K after2 lots10b5-1
Jul 2, 2026 (view filing)4:54 PM ETJun 302 daysKaye JackDirectorSSale−21.2K$46.44−$983.0K−44.9%26.0K after2 lots10b5-1
Jun 30, 2026 (view filing)Jun 264 daysAbi-Saab WalidChief Medical OfficerSSale−1.43K$46.86−$67.2K−0.8%168.2K after
Jun 26, 2026 (view filing)Jun 24-252 daysKapusta Matthew CCEO, Managing DirectorSSale−35.4K$50.02−$1.77M−6.4%519.2K after2 lots10b5-1
Jun 22, 2026 (view filing)Jun 17-185 daysKapusta Matthew CCEO, Managing DirectorSSale−206.1K$45.47−$9.37M−28.3%521.8K after8 lots10b5-1
Jun 22, 2026 (view filing)Jun 175 daysBalachandran MadhavanDirectorSSale−11.7K$45.06−$526.5K−21.3%43.3K after3 lots10b5-1
Jun 22, 2026 (view filing)Jun 175 daysKaye JackDirectorSSale−5.29K$42.57−$225.4K−16.9%26.0K after10b5-1
Jun 17, 2026 (view filing)Jun 152 daysBalachandran MadhavanDirectorSSale−10.0K$27.85−$278.5K−18.8%43.3K after10b5-1

Top 10 13F holders, Q2 2026

See all 257 holders

The largest institutional positions in uniQure N.V. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding QURE in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Avoro Capital Advisors LLC6,727,777$309.9M2.78%+768,182+12.9%Added
JPMorgan Chase & Co4,867,755$230.8M0.01%+2,030,289+71.6%Added
RTW Investments, LP3,941,572$181.5M1.55%+1,355,216+52.4%Added
State Street Corp2,903,825$133.8M0.00%+643,313+28.5%Added
Standard Life Aberdeen plc2,848,117$131.2M0.18%−2,458,269−46.3%Reduced
BlackRock, Inc.1,877,453$86.5M0.00%+143,995+8.3%Added
OrbiMed Advisors LLC1,807,486$83.3M1.58%−328,663−15.4%Reduced
Jane Street Group, LLC1,610,483$74.2M0.05%+974,488+153.2%Added
Jennison Associates LLC1,561,412$71.9M0.04%+327,623+26.6%Added
Boxer Capital Management, LLC1,503,300$69.2M5.21%+841,300+127.1%Added

Holders of 5% or more of QURE

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of uniQure N.V..

Largest holders of QURE from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Avoro Capital Advisors LLC13G/A9.87%6.15M shares+3.27 ppfrom 6.60%Aug 14, 20252 filingsFeb 17, 2026SEC
JPMorgan Chase & Co13G/A8.50%5.95M shares+1.50 ppfrom 7.00%Jul 16, 20262 filingsOct 16, 2026SEC
RTW Investments, LP13G5.70%3.94M shares+1.60 ppfrom 4.10%May 15, 20256 filingsAug 14, 2026SEC